Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Hemodialysis Patients
NCT01687699Phase 4Completed
- Sponsor
- Dialysis Outcomes Heart Failure Aldactone Study Group
- Start
- Apr 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in kidney failure (ESRD), sponsored by Dialysis Outcomes Heart Failure Aldactone Study Group. Started Apr 2008; status: completed.
02
Drugs
spironolactone
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT01687699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687699.